Clinical trials have demonstrated that Wegovy, when used alongside lifestyle modifications, can result in an average weight loss of approximately 15% of initial body weight over 68 weeks, as reported in the STEP 1 trial and referenced in NICE technology appraisal guidance (TA875)
"These guarantees are a natural extension of our founding missionto reverse chronic diseases like diabetes and obesity while reducing costs, said Virta co-founder and CEO Sami Inkinen
Current Protocols in Protein Science / Editorial Board, John E
Start with a 0.75 mg subcutaneous injection as the initial dose once a week
After giving yourself your dose in weeks one, two, and three, store it in the refrigerator
Cowan CS, Callaghan BL, Richardson R